HeartBeam Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Branislav Vajdic
Chief executive officer
US$3.3m
Total compensation
| CEO salary percentage | 13.2% |
| CEO tenure | no data |
| CEO ownership | 3.5% |
| Management average tenure | 1.5yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Companies Like HeartBeam (NASDAQ:BEAT) Could Be Quite Risky
Jan 17
HeartBeam gets a new chief medical officer
Oct 11HeartBeam gets patent to enable generation of its credit card-sized ECG, shares rise ~15%
Sep 28HeartBeam surges 54% on U.S. patent for ECG patch monitor to detect heart attacks
Sep 15HeartBeam GAAP EPS of $0.43 beats by $0.70
Aug 11HeartBeam: Cardiovascular Diagnostics On The Go
Dec 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$15m |
| Dec 31 2023 | US$3m | US$428k | -US$15m |
| Sep 30 2023 | n/a | n/a | -US$14m |
| Jun 30 2023 | n/a | n/a | -US$15m |
| Mar 31 2023 | n/a | n/a | -US$15m |
| Dec 31 2022 | US$1m | US$428k | -US$13m |
| Sep 30 2022 | n/a | n/a | -US$11m |
| Jun 30 2022 | n/a | n/a | -US$9m |
| Mar 31 2022 | n/a | n/a | -US$6m |
| Dec 31 2021 | US$485k | US$135k | -US$4m |
| Sep 30 2021 | n/a | n/a | -US$3m |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$1m |
| Dec 31 2020 | US$82k | US$82k | -US$1m |
| Dec 31 2019 | US$62k | US$62k | -US$536k |
Compensation vs Market: Branislav's total compensation ($USD3.25M) is above average for companies of similar size in the US market ($USD661.60K).
Compensation vs Earnings: Branislav's compensation has increased whilst the company is unprofitable.
CEO
Branislav Vajdic (68 yo)
no data
Tenure
US$3,250,743
Compensation
Dr. Branislav Vajdic, Ph D., serves as Chief Executive Officer and Director of HeartBeam, Inc., and is its Founder. He was President of HeartBeam, Inc. He co-founded NewCardio, Inc. and served as its Chief...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.3yrs | US$238.59k | 0.25% $ 165.7k | |
| Founder | no data | US$3.25m | 3.45% $ 2.3m | |
| President & Chief Business Officer | 1.3yrs | US$2.55m | 0% $ 0 | |
| Chief Technology Officer | 1.8yrs | US$1.41m | 0% $ 0 | |
| Member of Scientific Advisory Board & Chief Medical Officer | 1.6yrs | no data | no data | |
| Senior Vice President of Product | less than a year | no data | no data |
1.5yrs
Average Tenure
68yo
Average Age
Experienced Management: BEAT's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.3yrs | US$238.59k | 0.25% $ 165.7k | |
| Founder | no data | US$3.25m | 3.45% $ 2.3m | |
| Member of Scientific Advisory Board & Chief Medical Officer | less than a year | no data | no data | |
| Independent Director | less than a year | US$104.72k | 0.95% $ 631.0k | |
| Independent Director | no data | US$152.50k | 0.046% $ 30.7k | |
| Independent Director | less than a year | US$148.65k | no data | |
| Independent Director | no data | US$140.64k | 1.39% $ 928.0k | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | no data | US$140.00k | 0.27% $ 181.7k | |
| Chairman of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | less than a year | US$102.60k | 0.27% $ 176.7k | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
0.9yrs
Average Tenure
65yo
Average Age
Experienced Board: BEAT's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.